BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chao RY, Cheng CH, Wu SN, Chen PC. Defective trafficking of Kv2.1 channels in MPTP-induced nigrostriatal degeneration. J Neurochem 2018;144:483-97. [PMID: 29265365 DOI: 10.1111/jnc.14282] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Voronin MV, Kadnikov IA, Voronkov DN, Seredenin SB. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease. Sci Rep 2019;9:17020. [PMID: 31745133 DOI: 10.1038/s41598-019-53413-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
2 Justice JA, Manjooran DT, Yeh CY, Hartnett-Scott KA, Schulien AJ, Kosobucki GJ, Mammen S, Palladino MJ, Aizenman E. Molecular Neuroprotection Induced by Zinc-Dependent Expression of Hepatitis C-Derived Protein NS5A Targeting Kv2.1 Potassium Channels. J Pharmacol Exp Ther 2018;367:348-55. [PMID: 30190339 DOI: 10.1124/jpet.118.252338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Pergel E, Veres I, Csigi GI, Czirják G. Translocation of TMEM175 Lysosomal Potassium Channel to the Plasma Membrane by Dynasore Compounds. Int J Mol Sci 2021;22:10515. [PMID: 34638858 DOI: 10.3390/ijms221910515] [Reference Citation Analysis]
4 Lebowitz JJ, Pino JA, Mackie PM, Lin M, Hurst C, Divita K, Collins AT, Koutzoumis DN, Torres GE, Khoshbouei H. Clustered Kv2.1 decreases dopamine transporter activity and internalization. J Biol Chem 2019;294:6957-71. [PMID: 30824538 DOI: 10.1074/jbc.RA119.007441] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
5 Zhang L, Zheng Y, Xie J, Shi L. Potassium channels and their emerging role in parkinson's disease. Brain Res Bull 2020;160:1-7. [PMID: 32305406 DOI: 10.1016/j.brainresbull.2020.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Yeh CY, Ye Z, Moutal A, Gaur S, Henton AM, Kouvaros S, Saloman JL, Hartnett-Scott KA, Tzounopoulos T, Khanna R, Aizenman E, Camacho CJ. Defining the Kv2.1-syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant. Proc Natl Acad Sci U S A 2019;116:15696-705. [PMID: 31308225 DOI: 10.1073/pnas.1903401116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Xu X, Xu X, Hao Y, Zhu X, Lu J, Ouyang X, Lu Y, Huang X, Li Y, Wang J, Shen X. Antispasmodic Drug Drofenine as an Inhibitor of Kv2.1 Channel Ameliorates Peripheral Neuropathy in Diabetic Mice. iScience 2020;23:101617. [PMID: 33089105 DOI: 10.1016/j.isci.2020.101617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Saez NJ, Herzig V. Versatile spider venom peptides and their medical and agricultural applications. Toxicon 2019;158:109-26. [PMID: 30543821 DOI: 10.1016/j.toxicon.2018.11.298] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
9 Hsiao HT, Lu GL, Liu YC, Wu SN. Effective Perturbations of the Amplitude, Gating, and Hysteresis of IK(DR) Caused by PT-2385, an HIF-2α Inhibitor. Membranes (Basel) 2021;11:636. [PMID: 34436399 DOI: 10.3390/membranes11080636] [Reference Citation Analysis]
10 Daniel NH, Aravind A, Thakur P. Are ion channels potential therapeutic targets for Parkinson's disease? Neurotoxicology 2021;87:243-57. [PMID: 34699791 DOI: 10.1016/j.neuro.2021.10.008] [Reference Citation Analysis]
11 Bernardes CP, Menaldo DL, Zoccal KF, Boldrini-frança J, Peigneur S, Arantes EC, Rosa JC, Faccioli LH, Tytgat J, Sampaio SV. First report on BaltCRP, a cysteine-rich secretory protein (CRISP) from Bothrops alternatus venom: Effects on potassium channels and inflammatory processes. International Journal of Biological Macromolecules 2019;140:556-67. [DOI: 10.1016/j.ijbiomac.2019.08.108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]